Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Détails d'emballage: Emballage inerte pour l'expédition d'outre-mer
transport: Ocean,Land,Air,Express
Soutenir: 5000KGS MONTHLY
Hafen: QINGDAO,SHANGHAI,BEIJING
Saracatinib (AZD0530) est un inhibiteur de SRC de petite molécule orale développé par Astrazeneca. AZD0530 a pour effet d'augmenter la densité osseuse et de réduire la douleur pour la métastase osseuse des tumeurs malignes.
Product |
LOXO-292 |
CAS |
2152628-33-4 |
MF |
C29H31N7O3 |
MW |
525.6 |
Groupes de Produits : Intermédiaires API > LOXO-292 Intermédiaire
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.